Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-26-039290

Options or other derivatives

  • Director acquired 4,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Leftwich Scott Director 2026-08-17 Grant or award · Non-Qualified Stock Options (right to buy) +4,000 4,000 D
Loading xslF345X06/ownership.xml…